Abstract
The enzyme type IIA secreted phospholipase A2 (sPLA2-IIA) is crucial for mammalian innate host defense against bacterial pathogens. Most studies have investigated the role of sPLA2-IIA in systemic bacterial infections, identifying molecular pathways of bacterial resistance against sPLA2-IIA-mediated killing, and providing insight into sPLA2-IIA mechanisms of action. Sensitization of (antibiotic-resistant) bacteria to sPLA2-IIA action by blocking bacterial resistance or by applying sPLA2-IIA to treat bacterial infections might represent a therapeutic option in the future. Because sPLA2-IIA is highly expressed at mucosal barriers, we also discuss how sPLA2-IIA is likely to be an important driver of microbiome composition; we anticipate that future research in this area may bring new insights into the role of sPLA2-IIA in health and disease.
Original language | English |
---|---|
Pages (from-to) | 313-326 |
Number of pages | 14 |
Journal | Trends in immunology |
Volume | 41 |
Issue number | 4 |
Early online date | 6 Mar 2020 |
DOIs | |
Publication status | Published - Apr 2020 |
Keywords
- antimicrobial enzyme
- bacteria
- infections
- microbiome
- phospholipase
- virulence